[1]
“Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Updates and Pharmacological Associations”, RSD, vol. 13, no. 5, p. e13013545911, May 2024, doi: 10.33448/rsd-v13i5.45911.